Neumora | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Neumora Therapeutics is a clinical-stage biotechnology company dedicated to developing precision medicines for brain diseases. By integrating data science with neuroscience, the organization aims to create targeted therapies that address the unique biological and genetic characteristics of neuropsychiatric and neurodegenerative disorders. Focused on transforming drug development in this field, its mission parallels the transformative advancements made in oncology.

With a robust pipeline of eight potential best-in-class precision medicines, Neumora targets conditions such as Major Depressive Disorder, Alzheimer’s Disease, Schizophrenia, and Parkinson’s Disease, utilizing specific biomarkers and patient stratification strategies to enhance clinical efficacy. Collaborations with clinical investigator sites in the United States, Canada, and Sweden expand its clinical trial network. Supported by over $500 million in capital and a strategic partnership with Amgen, the organization is positioned to lead innovation in neuroscience drug development, addressing significant unmet needs among patients with complex brain diseases.